Lyophilized powder (White or slightly yellow product that becomes a transparent
solution when dissolved in normal saline)
Core Ingredients & Technology
Primary Active Ingredients
Clostridium Botulinum Toxin Type A (100 Units)
Mechanism of Action
Temporarily blocks the release of neurotransmitters in the muscles, inhibiting muscle
contraction and reducing muscle volume.
Key Technical Features
Manufactured using a vacuum-drying process. Pre-clinical studies (MRI and EMG on rat
models) demonstrate high muscle relaxation activity and volume reduction efficacy comparable to leading
global brands.
Temporary improvement of moderate to severe wrinkles and reduction of targeted muscle
volume.
Recommended/Targeted Areas
Glabellar wrinkles associated with the activity of the corrugator and/or procerus muscles
in adults between the ages of 19 and 65.
Usage Protocol
Recommended Application Method
Intramuscular injection.
Onset and Duration of Effect
Pre-clinical studies indicate significant muscle reduction from 4 weeks post-injection,
sustained up to 24 weeks.
Preparation Instructions
Dissolve in sterile normal saline to form a transparent solution prior to administration.
Storage & Handling
Required Storage Temperature
Refrigerated storage at 2–8°C in a sealed container.
Shelf Life
36 months from the manufacturing date.
General Handling Tips
Use immediately or within 24 hours after reconstitution.
Safety Information
Contraindications
Pregnant or breastfeeding women, individuals with hypersensitivity to botulinum toxin, patients with active
infections at the injection site, or those with neuromuscular disorders.
Safety Warnings
Professional medical use only. Avoid intravascular injection.
Common Temporary Side Effects
Localized pain, swelling, redness, bruising, or mild headaches.
Post-Treatment Care
Avoid rubbing or massaging the treated area.
Refrain from strenuous exercise or saunas for a few days post-treatment.
